SARS-CoV-2 Spike Protein XBB.1.5 Mutations Altered Four Conserved Antigenic Determinants
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27041940 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Ekrem Akbulut und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, Malatya Turgut Ozal University, 44900 Malatya, Türkiye. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, SARS-CoV-2, Mutation. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Inonu University, Inonu University Scientific Research Projects Unit.
Abstract (Originalsprache)
The continuous evolution of SARS-CoV-2 affects its infectivity and ability to evade the immune system. The XBB.1.5 subvariant carries numerous mutations compared to previous Omicron variants and exhibits significant evasion of polyclonal neutralizing antibodies. In this study, the mechanistic effects of mutations in the XBB.1.5 spike protein on structural stability, antigenic markers, and antibody epitopes were analyzed using homology modeling, epitope prediction, protein stability analysis, coarse-grained dynamic simulations, and chain-specific interface mapping. Thirty-eight amino acid substitutions were identified relative to Wuhan-Hu-1, including 22 in the receptor-binding region. The prefusion trimeric fold was conserved, with localized rearrangements in the N-terminal domain, receptor-binding domain, and S1/S2 region. Linear B-cell epitope prediction yielded similar epitope counts and length distributions in wild-type and XBB.1.5, but only moderate residue-level overlap (Jaccard ≈ 0.40–0.62), indicating epitope turnover and alteration of four conserved antigenic determinants. Functional screening suggested that ~45% of substitutions could affect protein function. Chain-specific interface analysis of the A–B protomer interface indicated preserved inter-protomer coupling with modest repacking of the polar/directional contacts. Overall, XBB.1.5 appears to maintain ACE2 engagement while redistributing antibody targets, underscoring the need for updated vaccine formulations and therapeutic antibodies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bioengineering, Malatya Turgut Ozal University, 44900 Malatya, Türkiye.
- Department of Biomedical Engineering, Malatya Turgut Ozal University, 44900 Malatya, Türkiye.
- Department of Biology, Inonu University, 44280 Malatya, Türkiye.
Förderung
- Inonu University
- Inonu University Scientific Research Projects Unit
Zitieren
APA
Akbulut, E., Yildirim, M., & Kahraman, H. (2026). SARS-CoV-2 Spike Protein XBB.1.5 Mutations Altered Four Conserved Antigenic Determinants. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27041940
Vancouver
Akbulut E, Yildirim M, Kahraman H. SARS-CoV-2 Spike Protein XBB.1.5 Mutations Altered Four Conserved Antigenic Determinants. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27041940
BibTeX
@article{Akbulut2026,
author = {Akbulut, Ekrem and Yildirim, Meltem and Kahraman, Huseyin},
title = {SARS-CoV-2 Spike Protein XBB.1.5 Mutations Altered Four Conserved Antigenic Determinants},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27041940}
}
EUVIMED